Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOPOTECAN\TOPOTECAN for Bone marrow conditioning regimen: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 12 adverse event reports in the FDA FAERS database where TOPOTECAN\TOPOTECAN was used for Bone marrow conditioning regimen.

Most Reported Side Effects for TOPOTECAN\TOPOTECAN

Side Effect Reports % Deaths Hosp.
Disease progression 111 21.7% 64 3
Neutropenia 44 8.6% 4 4
Drug resistance 35 6.9% 34 0
Mucosal inflammation 24 4.7% 4 6
Bone marrow failure 23 4.5% 10 3
Bronchospasm 23 4.5% 0 0
Malignant neoplasm progression 22 4.3% 10 2
Nausea 20 3.9% 10 10
Anaemia 18 3.5% 4 10
Hypertension 18 3.5% 1 2
Infection 18 3.5% 3 1
Pancytopenia 18 3.5% 6 9
Death 17 3.3% 17 1
Off label use 17 3.3% 4 2
Febrile neutropenia 16 3.1% 6 6

Other Indications for TOPOTECAN\TOPOTECAN

Retinoblastoma (86) Ovarian cancer (70) Neuroblastoma (53) Nephroblastoma (28) Small cell lung cancer (19) Cervix carcinoma (17) Neoplasm (17) Congenital retinoblastoma (16) Product used for unknown indication (16) Ewing's sarcoma (10)

Other Drugs Used for Bone marrow conditioning regimen

FLUDARABINE (6,080) BUSULFAN (4,669) CYCLOPHOSPHAMIDE (4,485) MELPHALAN (2,368) LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (1,884) THIOTEPA (1,551) ALEMTUZUMAB (1,122) ETOPOSIDE (936) CYTARABINE (833) THYMOCYTE IMMUNE GLOBULIN NOS (742)

Related Pages

TOPOTECAN\TOPOTECAN Full Profile All Bone marrow conditioning regimen Drugs TOPOTECAN\TOPOTECAN Demographics TOPOTECAN\TOPOTECAN Timeline